ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Morale, Money Woes Hit MD Anderson

January 18, 2013

NCI Advisory Group, Other Cancer Meetings For May, June

April 30, 1976

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In

October 10, 2014

In Brief: Bertino Moves To MSK As Head Of Chemotherapy Research; Rosemary Clive Laves ACOS For Elm

January 2, 1987

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980